These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20834076)

  • 41. Immunohistochemical evaluation of cyclin D1 in breast cancer.
    Bilalović N; Vranić S; Basić H; Tatarević A; Selak I
    Croat Med J; 2005 Jun; 46(3):382-8. PubMed ID: 15861516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of HER-2/neu overexpression with the number of involved axillary lymph nodes in hormone receptor positive breast cancer patients.
    Tokatli F; Altaner S; Uzal C; Ture M; Kocak Z; Uygun K; Bilgi S
    Exp Oncol; 2005 Jun; 27(2):145-9. PubMed ID: 15995634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of BRCA1 expression in sporadic breast carcinomas.
    Lambie H; Miremadi A; Pinder SE; Bell JA; Wencyk P; Paish EC; Macmillan RD; Ellis IO
    J Pathol; 2003 Jun; 200(2):207-13. PubMed ID: 12754741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
    van der Vegt B; de Roos MA; Peterse JL; Patriarca C; Hilkens J; de Bock GH; Wesseling J
    Histopathology; 2007 Sep; 51(3):322-35. PubMed ID: 17645748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BRCA1 gene expression in breast cancer: a correlative study between real-time RT-PCR and immunohistochemistry.
    Al-Mulla F; Abdulrahman M; Varadharaj G; Akhter N; Anim JT
    J Histochem Cytochem; 2005 May; 53(5):621-9. PubMed ID: 15872055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Expression of BRCA1 and WWOX and their clinicopathologic implication in breast carcinomas occurring in young women].
    Zhang QL; Zhang QH; Cong H; Zhang XL
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):90-4. PubMed ID: 23710914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of BRCA1 protein in breast cancer and its prognostic significance.
    Rakha EA; El-Sheikh SE; Kandil MA; El-Sayed ME; Green AR; Ellis IO
    Hum Pathol; 2008 Jun; 39(6):857-65. PubMed ID: 18400253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of a BRCA1 peptide validates MS110 as a BRCA1-specific antibody in immunohistochemistry.
    Alamshah A; Springall R; Gillett CE; Solomon E; Morris JR
    Histopathology; 2008 Jul; 53(1):117-20. PubMed ID: 18462360
    [No Abstract]   [Full Text] [Related]  

  • 49. Frequent loss of BRCA1 nuclear expression in young women with breast cancer: an immunohistochemical study from an area of low incidence but early onset.
    Lee WY
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):310-5. PubMed ID: 12607598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synchronous ovarian dysgerminoma and breast carcinoma in a patient with positive immunostain of BRCA1.
    Băltătescu GI; Așchie M; Sârbu V
    Chirurgia (Bucur); 2013; 108(2):259-63. PubMed ID: 23618579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A mutation in the 5' untranslated region of the BRCA1 gene in sporadic breast cancer causes downregulation of translation efficiency.
    Wang J; Lu C; Min D; Wang Z; Ma X
    J Int Med Res; 2007; 35(4):564-73. PubMed ID: 17697535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of proteins involved in DNA damage response in familial and sporadic breast cancer patients.
    Partipilo G; Simone G; Scattone A; Scarpi E; Azzariti A; Mangia A
    Int J Cancer; 2016 Jan; 138(1):110-20. PubMed ID: 26205471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SUMOylation proteins in breast cancer.
    Alshareeda AT; Negm OH; Green AR; Nolan C; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2014 Apr; 144(3):519-30. PubMed ID: 24584753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Runx2 in human breast carcinoma: its potential roles in cancer progression.
    Onodera Y; Miki Y; Suzuki T; Takagi K; Akahira J; Sakyu T; Watanabe M; Inoue S; Ishida T; Ohuchi N; Sasano H
    Cancer Sci; 2010 Dec; 101(12):2670-5. PubMed ID: 20946121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [BRCA1 expression in benign and malignant breast lesions].
    Fernández Á; Reigosa A
    Invest Clin; 2016 Dec; 57(4):330-51. PubMed ID: 29938981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BRCA1, C-erbB-2, and H-ras gene expressions in young women with breast cancer. An immunohistochemical study.
    Ozer E; Sis B; Ozen E; Sakizli M; Canda T; Sarioğlu S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):12-8. PubMed ID: 10937043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer.
    Maacke H; Opitz S; Jost K; Hamdorf W; Henning W; Krüger S; Feller AC; Lopens A; Diedrich K; Schwinger E; Stürzbecher HW
    Int J Cancer; 2000 Dec; 88(6):907-13. PubMed ID: 11093813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays.
    Mahmoud AM; Macias V; Al-Alem U; Deaton RJ; Kadjaksy-Balla A; Gann PH; Rauscher GH
    PLoS One; 2017; 12(9):e0184385. PubMed ID: 28863181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the Na(+)/I(-) symporter in invasive ductal breast cancer.
    Rudnicka L; Sińczak A; Szybiński P; Huszno B; Stachura J
    Folia Histochem Cytobiol; 2003; 41(1):37-40. PubMed ID: 12705478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study.
    Pérez-Vallés A; Martorell-Cebollada M; Nogueira-Vázquez E; García-García JA; Fuster-Diana E
    J Clin Pathol; 2001 Jun; 54(6):476-80. PubMed ID: 11376024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.